Evidence map›Paper›PMID 31305532›Full record

ArticleJournal of visualized experiments : JoVE2019

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate.

Michael Kalwat, Melanie H Cobb

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. High-Throughput Screening for Insulin Secretion Modulators.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael KalwatDepartment of Pharmacology, University of Texas Southwestern Medical Center; Michael.Kalwat@utsouthwestern.edu.
Melanie H CobbDepartment of Pharmacology, University of Texas Southwestern Medical Center.
The University of Texas Southwestern Medical Center · US

Funding

Insulin-Regulated MAP Kinase PathwaysR37DK034128 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI COBB, MELANIE H. · 2007 to 2016
$5.1M
Role of isoxazole compounds in beta cell differentiation and functionF32DK100113 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI KALWAT, MICHAEL ANDREW · 2013 to 2016
$161k
NIDDK NIH HHS F32 DK100113NIDDK NIH HHS R37 DK034128
6 · The paper itself

Abstract

Performing antibody-based assays for secreted insulin post-sample collection usually requires a few hours to a day of assay time and can be expensive, depending on the specific assay. Secreted luciferase assays expedite results and lower the assay cost per sample substantially. Here we present a relatively underused approach to gauge insulin secretory activity from pancreatic β cells by using Gaussia luciferase genetically inserted within the C-peptide. During proteolytic processing of proinsulin, the C-peptide is excised releasing the luciferase within the insulin secretory vesicle where it is co-secreted with insulin. Results can be obtained within minutes after sample collection because of the speed of luciferase assays. A limitation of the assay is that it is a relative measurement of insulin secretion and not an absolute quantitation. However, this protocol is economical, scalable, and can be performed using most standard luminescence plate readers. Analog and digital multichannel pipettes facilitate multiple steps of the assay. Many different experimental variations can be tested simultaneously. Once a focused set of conditions are decided upon, insulin concentrations should be measured directly using antibody-based assays with standard curves to confirm the luciferase assay results.

Indexed as

Insulin SecretionAnimalsCell LineGenes, ReporterGlucoseHumansInsulin-Secreting CellsLuciferasesMiceGlucoseLuciferases

Identifiers

PMID31305532
PMCPMC8817685
OpenAlexW2956020452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.